It’s no secret that the demand for cell and gene therapies is growing. But what should the industry prioritize to improve manufacturing?

How many times have you heard phrases like: “gene therapy is a rapidly evolving industry with the potential to transform patients’ lives?”

I hope 2024 brings success to you and your companies – and better health (or even cures) to your patients.

Recent research has resulted in a new type of CAR-T therapy that targets non-cancer cells

Do you think PRINT will stand the test of time – or will better options supersede its development?

It’s a good news week: the FDA has approved the first cell therapy to treat unresectable or metastatic melanoma

Sterility testing is difficult for autologous cell and gene therapies because of limited volumes and the need for speed.

In light of cabotegravir’s positive opinion for sexually acquired HIV-1, I wanted to explore the history and politics of HIV/AIDS drug development

Researchers demonstrate that complex data analysis paired with artificial intelligence can predict additional causes of Teratogenicity

Studying the link between Alzheimer’s risk, estrogen levels, and menopausal status in women